Companion Diagnostics Market to reach a market size of $6.5 billion by 2025


Posted October 9, 2019 by kbv_research

The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.

 
According to a new report Global Companion Diagnostics Market, published by KBV Research, The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.

The Polymerase Chain Reaction (PCR) market dominated the Global Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 20.3% during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 19.1% during (2019-2025).

The Oncology market dominated the Global Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 21.1 % during the forecast period. The Neurology market is expected to witness a CAGR of 18.3% during (2019-2025).

The North America market dominated the Global Lung Cancer Companion Diagnostics by Region in 2018, growing at a CAGR of 21.7 % during the forecast period. The Europe market is expected to witness a CAGR of 19.9% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 23.5% during (2019-2025).

Full Report: https://www.kbvresearch.com/companion-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.

Global Companion Diagnostics Market Segmentation

By Technology

Immunohistochemistry
Polymerase chain reaction (PCR)
Next generation sequencing (NGS)
In Situ Hybridization and
Other Technology

By Indication

Oncology
Neurology and
Other Indications

By Cancer Type

Breast Cancer
Colorectal Cancer
Lung Cancer
Blood Cancer and
Other Cancer Type

By Geography

North America

US
Canada
Mexico
Rest of North America

Europe

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
South Korea
Singapore
Australia
Rest of Asia Pacific

LAMEA

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

Agilent Technologies, Inc.
Almac Group
ARUP Laboratories, Inc.
Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
Danaher Corporation
Thermo Fisher Scientific, Inc.
Hologic, Inc.
Novartis AG
Illumina, Inc.
Qiagen N.V.

Companion Diagnostics Market Related Reports:

North America Market
Europe Market
Asia Pacific Market
LAMEA Market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By KBV Research
Phone 6466616066
Business Address 244 Fifth Avenue, Suite 1407 New York, N.Y. 10001 United States (U.S)
Country United States
Categories Health
Tags Companion Diagnostics Market Size , Companion Diagnostics Market , KBV Research , Companion Diagnostics
Last Updated October 9, 2019